2022
DOI: 10.1016/j.rechem.2022.100322
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis of benzoyl esters of β-amyrin and lupeol and evaluation of their antibiofilm and antidiabetic activities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
14
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 19 publications
(14 citation statements)
references
References 39 publications
0
14
0
Order By: Relevance
“…The β-glucosidase inhibition test was assessed as previously described [62]. Briefly, a reaction mixture was obtained from 15 µL phosphate buffer (pH 5.0), 20 µL p-nitrophenylβ-D-glucopyranoside (1mg/mL, Sigma-Aldrich ® ) and 20 µL sample or positive control at different concentrations.…”
Section: In Vitro Evaluation Of the Antidiabetic Activitymentioning
confidence: 99%
“…The β-glucosidase inhibition test was assessed as previously described [62]. Briefly, a reaction mixture was obtained from 15 µL phosphate buffer (pH 5.0), 20 µL p-nitrophenylβ-D-glucopyranoside (1mg/mL, Sigma-Aldrich ® ) and 20 µL sample or positive control at different concentrations.…”
Section: In Vitro Evaluation Of the Antidiabetic Activitymentioning
confidence: 99%
“…12,15 This EPS selfsecreted polymer matrix provides a scaffold and protective barrier to embedded cells against various stresses such as bacteriophages and host immune responses making them able to resist antimicrobial treatments up to 1000 times more than their planktonic counterparts. [37][38][39] Biofilms contribute to chronic infections that are difficult to treat with ordinary antibiotics. 40 Thus, the inhibition of biofilm production and QS can disrupt the development of the protective three-dimensional structure providing a lead-way for the development of new antiinfective agents.…”
Section: Introductionmentioning
confidence: 99%
“…Despite the development of conventional antimicrobials as solutions, there is a multidrug-resistant pattern in Gram-positive and Gram-negative bacteria, as well as in fungi, resulting in difficult-to-treat or even untreatable infections. 10,[12][13][14] Millions of people suffer from microbial infections, some of which are caused by resistant strains, accounting for millions of deaths worldwide each year. 15 Bacterial biofilms are responsible for approximately 80% of severe and recurrent microbial infections in humans, and microbial cells living within biofilms maybe 10-1000 times more resistant to antibiotics than their planktonic counterparts.…”
Section: Introductionmentioning
confidence: 99%